Quick Answer
NEOGENOMICS INC reported Stockholders Equity of $836.56 million for the year ending 2025.
- NEOGENOMICS INC showed a decrease of -7.3% in Stockholders Equity from 2024 to 2025.
- This data is from NEOGENOMICS INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $22.50 million | Q2 2014: $23.13 million | Q3 2014: $59.07 million | Q1 2015: $60.16 million | Q2 2015: $60.87 million | Q3 2015: $61.85 million | Q1 2016: $206.00 million | Q2 2016: $203.63 million | Q3 2016: $200.79 million | Q1 2017: $168.59 million | Q2 2017: $168.90 million | Q3 2017: $169.53 million | Q1 2018: $171.99 million | Q2 2018: $164.21 million | Q3 2018: $303.56 million | Q1 2019: $323.85 million | Q2 2019: $489.73 million | Q3 2019: $497.01 million | Q1 2020: $505.04 million | Q2 2020: $654.23 million | Q3 2020: $666.36 million | Q1 2021: $843.71 million | Q2 2021: $1.15 billion | Q3 2021: $1.14 billion | Q1 2022: $1.08 billion | Q2 2022: $1.04 billion | Q3 2022: $1.01 billion | Q1 2023: $974.46 million | Q2 2023: $956.19 million | Q3 2023: $947.43 million | Q1 2024: $923.41 million | Q2 2024: $915.88 million | Q3 2024: $908.21 million | Q1 2025: $888.27 million | Q2 2025: $854.04 million | Q3 2025: $838.29 million.
- Over the full 14 years of available data (2012 to 2025), NEOGENOMICS INC's Stockholders Equity has grown by 8,977.3%.
- Historical annual values: Fiscal year 2025: $836.56 million | Fiscal year 2024: $902.34 million | Fiscal year 2023: $941.54 million | Fiscal year 2022: $998.02 million | Fiscal year 2021: $1.11 billion | Fiscal year 2020: $694.29 million | Fiscal year 2019: $507.41 million | Fiscal year 2018: $320.44 million | Fiscal year 2017: $171.96 million | Fiscal year 2016: $162.32 million | Fiscal year 2015: $208.52 million | Fiscal year 2014: $60.41 million | Fiscal year 2013: $21.71 million | Fiscal year 2012: $9.22 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: